Webinar: Optimising viral vector manufacturing with CDMO expertise and innovation

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category

Delivering life-changing therapies 

At OXB we are deeply committed to producing high-quality viral vectors, recognizing their crucial role in cell and gene therapies that bring hope to patients around the world. Backed by decades of experience and deep technical expertise, our CDMO solutions are trusted by some of the world’s top cell and gene therapy companies.

Your inquiry is important to us, and we are dedicated to providing you with the highest level of service and expertise. Complete our contact form and our team will review your message and get in touch shortly. Or if you want to contact our state-of-the-art facilities directly please see below the phone numbers.

Contact partnering@oxb.com for more information regarding our CDMO services.

Shareholders and Investors please select "Shareholder and Investor Enquiries" on our form

Media enquiries: Please call +44 (0)20 3709 5700 or email OXB@icrhealthcare.com

OXB-UK-Headquarters-832x480px

Headquarters

Registered address

+44 (0) 1865 783 000

OXB-UK-Oxbox-832x480px

Oxbox

Manufacturing facility

+44 (0) 1865 783 000

OXB-UK-Harrow-House-832x480px

Harrow House

Manufacturing facility

+44 (0) 1865 783 000

OXB-US-Bedford-832x480px

Oxford Biomedica (US) LLC

(001) 781.428.4536

*Please note this is a US phone number; if calling outside the US, please use country code 001

OXB-US-Durham-832x480px

Oxford Biomedica (US) LLC

1733 TW Alexander Drive
Durham, NC
27703

OXB-France-Strasbourg-832x480px

Oxford Biomedica (France) SAS

+33 3 88 55 10 00